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Objective: Computed tomographic angiography (CTA) has the potential to detect unsuspected extravascular pathology in
patients with vascular disease. The purpose of this study was to determine the prevalence of unexpected findings,
additional associated costs, and alterations in treatment in vascular patients undergoing CTA.
Methods: During a recent 15-month period, 350 subjects (207 men, 143 women; mean age of 66  14 years) underwent
CTA for evaluation of aortic aneurysms (43%), lower extremity occlusive disease (33%), renal artery disease (17%), or
aortic graft infection (7%). Unexpected CTA findings were categorized as incidental, clinically important but probably
benign, or possibly serious. Medical records were reviewed to determine the outcome of additional testing and to identify
alterations in treatment plans.
Results: Of the 163 subjects (47%) with positive findings, 95 (27%) were categorized as incidental, 27 (8%) as probably
benign, and 41 (12%) as potentially serious. Additional tests were required in 57 subjects (15%) to confirm these results.
Seventeen (5%) of the 350 original subjects were ultimately considered to have life-threatening pathology found on CTA,
but 11 of these were lost to follow-up. Significant alterations in treatment plan occurred in the six patients with
life-threatening pathology and in one other patient with benign disease.
Conclusions: These data suggest that unexpected CTA findings are common in vascular patients. Although few prove to
be serious, treatment delays associated with evaluation of benign lesions are modest. Of major concern, one fourth of
patients with potentially serious lesions did not undergo further evaluation in this study. Vascular surgeons need to
ensure adequate follow-up for their patients with potentially serious extravascular lesions. (J Vasc Surg 2006;44:998-1001.)Computed tomographic angiography (CTA) is rapidly
replacing catheter-based arteriography as the standard for
evaluation of peripheral arterial disease (PAD). In addition
to being less invasive, CTA has been shown to be at least
equivalent to digital subtraction angiography (DSA) in the
initial work-up of patients with PAD.1-3 The introduction
of multidetector array technology and the ability to create
three-dimensional (3D) reconstructions have resulted in
improved imaging capability that is not available with stan-
dard angiography.
CTA carries an additional potential benefit over DSA: it
allows detection of extravascular pathology. As shown pre-
viously in studies of patients undergoing CT for renal colic4
or CT colonography for colon cancer screening,5 the inci-
dence of unsuspected but clinically important findings is
relatively high (23% and 14%, respectively). The potential
to discover clinically important pathology is particularly
germane in patients with vascular disease. Owing to ad-
vanced age and prevalent risk factors such as smoking, these
individuals are predisposed to other life-threatening dis-
eases, especially malignancies.6 Detection of extravascular,
life-threatening pathology may lead to informed treatment
decisions that impact the timing and type of vascular inter-
vention.
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998On the other hand, detection of an unsuspected lesion
that proves to be benign may lead to increased hospital
costs, increased patient anxiety, and unnecessary delay in
treatment. The purposes of this study were to determine
(1) the prevalence of unexpected extravascular findings in
vascular patients undergoing CTA, (2) the proportion of
patients in whom extravascular findings altered the treat-
ment plan, and (3) the proportion of patients who required
additional tests to characterize unsuspected lesions noted
by CTA.
METHODS
The study was approved by the University of Texas
Southwestern Medical Center Institutional Review Board.
We reviewed the results of all CTAs performed for evalua-
tion of PAD between November 2003 and January 2005 at
Parkland Memorial Hospital and the University of Texas
Southwestern University Hospitals. CTA studies were per-
formed on multidetector row CT scanners, and images
were transferred off-line to a dedicated workstation for 3D
vascular reconstructions and multiplanar imaging. Vascular
and nonvascular findings were interpreted by attending
interventional radiologists, and all findings were recorded
in a written report from the Department of Radiology.
The information obtained from these sources was patient
demographics, study indication, vascular findings, and
nonvascular findings.
The nonvascular findings were further categorized as
incidental (eg, gallstones or renal cysts), clinically impor-
tant but probably benign (eg, adrenal masses, 1 to 3 cm), or
possibly serious (eg, suspicious solid organ lesions or lung
nodules 1 cm). Ambiguous solid organ lesions were
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lished criteria,7 an adrenal mass was considered to be po-
tentially serious if it measured 3 cm in diameter or 10
Hounsfield units (HU) in density. Solid renal lesions were
identified by HU 20 with evidence of enhancement.
Complex cystic lesions were categorized using the Bosniak
classification scheme, as accepted for renal cystic lesions.8
Medical records of the subjects with lesions categorized
as probably benign or potentially serious were reviewed to
determine the outcome of additional testing and to identify
alterations in the treatment plans. In cases where follow-up
was incomplete, subjects were contacted by telephone, and
additional tests were scheduled as indicated.
Continuous data are expressed as mean  standard
deviation of the mean. Univariate comparison of variables
associated with the presence of suspicious lesions was
performed with 2 test. Continuous measures were eval-
uated with the Student t test. Significance was deter-
mined at the P  .05 level.
RESULTS
During the study period, 350 consecutive patients
(mean age, 66  14 years) underwent CTA for evaluation
of vascular disease. There were 207 men (59%) and 143
(41%) women. Indications for CTA were aneurysmal dis-
ease in 150 (43%), lower extremity occlusive disease in
115 (33%), suspected renal artery disease in 60 (17%),
and aortic graft infection in 25 (7%). A total of 130 CTA
studies (37%) were performed in the public hospital (Park-
land Memorial Hospital), and 220 (63%) were performed
in the private hospital (University of Texas Southwestern
University Hospitals).
A total of 163 subjects (47%) had at least one nonvas-
cular finding on CTA (Fig). No lesions were suspected on
clinical grounds. Lesions were categorized as incidental in
95 subjects (27%), as probably benign in 27 (8%), and
potentially serious in 41 (12%) (Table I). Of the 27 subjects
350 subjects
187 no unsuspected 
findings
163 with positive
findings
95 incidental27 probably 
benign 
41 potentially 
serious
27 confirmed 
benign 
24 confirmed
benign 
6 life-threatening
11 no
follow-up 
11 highly suspicious 
30 follow-up
tests
17 serious 
Fig. Flow chart of extravascular findings found on patients under-
going computed tomographic angiography for evaluation of vas-
cular disease.with lesions considered probably benign, 23 had one lesionand four had two lesions. Of the 41 subjects with poten-
tially serious lesions, 36 had one lesion and five had two
lesions in this category. To confirm these findings, addi-
tional tests were done in 57 of the 68 patients with clinically
significant lesions (ie, probably benign or potentially seri-
ous). Vascular surgery was delayed for a mean of 14 weeks
in six (11%) of the 57 subjects; additional testing was
performed in the remainder after vascular reconstruction.
The benign nature of the lesions was confirmed in all 27
subjects in the “probably benign” group.
Additional testing was also done in 30 of the 41 sub-
jects with potentially serious findings: 24 had benign le-
sions, and six had life-threatening pathology (5 occult
malignancies, 1 unsuspected pulmonary embolus). Eleven
others with lesions that were highly suggestive of malig-
nancy were lost to follow-up or refused additional testing.
These included solid liver lesions 2 cm in 3 patients,
adrenal masses 3 cm in 2 patients, complex renal masses
in 2 patients, and the following lesions in 1 patient each: a
Table I. Categorization of unexpected extravascular
findings in 163 of 350 subjects undergoing computed
tomographic angiography for evaluation of peripheral
arterial disease
Lesions Patients (n)
Incidental lesions
Bilateral adrenal hyperplasia 16
Adrenal nodule 1 cm 4
Mesenteric lymphadenopathy 3
Diverticulosis 11
Inguinal hernia 8
Hepatic or pancreatic cyst 10
Uterine fibroid 1
Polycystic kidney disease 10
Renal atrophy 5
Nephrolithiasis 2
Cardiomegaly 1
Gallstones 18
Intestinal wall thickening 4
Hepatosplenomegaly 2
Total 95
Probably benign lesions
Adrenal nodule  1 cm 17
2 cm splenic aneurysm 1
Renal mass (HU 10-20) 3
Lung nodule 1 cm 4
Thyroid nodule 1
Hydronephrosis 1
Total 27
Potentially serious lesions
Adrenal mass (3 cm or HU 10) 10
Pelvic mass 3
Renal mass (HU 20) 7
Lung nodule 1 cm, lymphadenopathy 12
Pulmonary embolism 1
Pancreatic mass 1
Colon mass 1
Thickened duodenum, surrounding fluid 1
Suspicious hepatic lesions 5
Total 41large pelvic mass, a lung nodule with associated lymphad-
ortisol
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adrenal mass suggestive of metastatic disease, and a
1.5-cm adrenal lesion highly suggestive for malignancy
(HU 50). None of the 11 patients returned for addi-
tional testing despite several attempts at contact by
telephone and certified mail. Interestingly, of these 11
patients who refused further testing, seven were treated at
our private institution and four at our public hospital.
Including the 11 lost patients with highly suggestive
lesions, 17 (5%) of the 350 original patients had life-
threatening pathology. Comparing the 17 subjects with
life-threatening pathology with the 333 subjects without
serious lesions, there was no significance differences in
mean age (70  12 years vs 69  50 years, P  .93), the
proportion of women (both 41%), or the proportion
treated in the private hospital system (77% vs 62%, P 
.35). Life-threatening pathology was present in 8 (5.3%)
of the 150 subjects with aortic aneurysms, 4 (3.5%) of the
115 with occlusive disease, 3 (5%) of the 60 with suspected
renal artery disease, and 2 (8%) of the 25 with graft infec-
tions; these differences are not significant.
DISCUSSION
The widespread application of CT scanning since the
1970s has increased the detection of ambiguous pathology.
Table II. Follow-up tests performed to evaluate clinically
tomographic angiography
Finding Finding(n) Follow-up studies (n)
Adrenal nodule 27 CTA†
Abdominal CT
Functional studies†
Abdominal MRI
Adrenal sampling
Splenic aneurysm 1 None
Renal mass 10 Abdominal CT
Abdominal US
Abdominal MRI
Urology consult
Lung nodule 16 CTA
Chest CT
CT/PET
Pulmonary consult
Thyroid nodule 1 Thyroid US
Hydronephrosis 1 Urology consult
Pelvic mass 3 Transvaginal US
Gynecology consult
Pulmonary embolism 1 None
Pancreatic mass 1 CT-FNA
General Surgery consult
Colon mass 1 Colonoscopy
Thickened duodenum 1 UGI series
Suggestive liver lesion 5 Abdominal CT
Abdominal US
CTA, Computed tomographic angiography;US, ultrasonography;MRI,ma
aspiration; UGI, upper gastrointestinal series.
*Lesions not accounted for were in patients who were lost to follow-up.
†CTAs were done to follow-up vascular disease.
‡Functional studies included 24-hour urine collections for metanephrine, cMost of these lesions ultimately prove to be clinicallyunimportant, such as unsuspected adrenal nodules.9 Nev-
ertheless, physicians are often compelled to obtain addi-
tional tests to further characterize these abnormalities,
which results in increased medical costs and patient incon-
venience. CTA has advantages over more invasive angio-
graphic studies in vascular patients, but the discovery of
unsuspected lesions carries the burden of increased costs
and treatment delays associated with additional testing. On
the other hand, recognition of life-threatening lesions that
are clinically unsuspected may significantly alter treatment
plans.
Our data suggest that unexpected extravascular find-
ings are detectable in nearly 50% of patients undergoing
CTA to evaluate PAD. Most of these lesions are readily
classified as clinically insignificant, and no further testing is
required. Although additional testing may be required in
about one in six patients, treatment delays are minimal.
Life-threatening pathology was found in 5% of our patients,
which is in keeping with the prevalence of serious extraco-
lonic pathology detected on screening CT colonography.5
We could not identify any clinical markers that were asso-
ciated with life-threatening pathology. Most important,
these lesions would not have been identified without CTA.
Although these data may support more widespread use
of CTA to evaluate patients with vascular disease, the
rtant extravascular findings found on computed
erformed (n) Diagnosis at follow-up (n)*
9 Adenoma (23)
3 No nodule (1)
12
1
1
1 Cyst (6)
4 No mass found (2)
4
2
1 Benign nodule (9)
10 Pulmonary fibrosis 1
3 No nodule (2)
1 Lung cancer (2)
1 Cyst (1)
2 Benign hydronephrosis (1), Prostate cancer (1)
1 Hydrosalpinx (1)
1 Ovarian cyst (1)
1 Adenocarcinoma (1)
1
1 Benign polyps (1)
1 Normal duodenum (1)
2 Hemangioma (1)
2 Metastatic melanoma (1)‡
resonance imaging; PET, positron emission tomography; FNA, fine needle
, and aldosterone.impo
P
gneticrelatively few patients with life-threatening pathology pre-
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ther limited by the retrospective nature of this study. To
determine the value of CTA, one must examine the risks of
not performing this test in vascular patients. Comparing
CTA to tests which do not detect extravascular pathology
would require larger studies, carefully defined patient selec-
tion criteria, and longitudinal follow-up.
A major problem identified by this study was the subset
of 11 patients with potentially life-threatening problems
who were lost to follow-up. Others have reported similar
problems with follow-up in patients undergoing CT scans
for a variety of indications. For example, in one series by
Katz et al,10 47% of patients considered to have suggestive
lesions onCTAwere lost to follow-up. In the present study,
27% of patients with suggestive lesions were lost to follow-
up. This might be less surprising in a public teaching
hospital, in which patient compliance may adversely impact
continuity of care, but a higher proportion of patients lost
to follow-up were treated in the private hospital system.
The hospital-specific rate of patients with suggestive
lesions who were lost to follow-up did not reach statistical
significance in the current study, but this trend is alarming.
We have since educated the medical staff about this prob-
lem and have instituted a new notification system in which
ordering physicians now receive alerts by electronic mail
about extravascular findings. As the index physician re-
questing the CTA, the vascular surgeon remains ultimately
responsible to review all CTA reports for any unexpected
findings and to ensure a proper work-up as indicated.
Although this is a large analysis of consecutive patients
undergoing CTA for evaluation of PAD, a number of
limitations must be acknowledged. The study is retrospec-
tive in design. Thus, the prevalence of extravascular find-
ings may be under-estimated, especially since the CTAs
were not re-reviewed specifically for this study.
The results may also have been affected by interobserver
variability. The interobserver variability for detecting extravas-
cular lesions on CTA in patients with vascular disease has not
been reported, but previous studies indicate good interob-
server agreement in CT scans performed for other indica-
tions.11-13 Despite these potential limitations, our findings are
similar to those of previous studies that have evaluated unsus-
pected pathology in patients undergoing CT scans for other
indications.4,5,10
Another potential limitation is that we cannot be sure that
all of the lesions detected in the 11 patients who were lost to
follow-up would have proven to be malignant. We acknowl-
edge that we may have overestimated the total percentage of
patients undergoing CTA who can be expected to have seri-
ous extravascular pathology. Nevertheless, our findings are in
keeping with those of Katz et al,10 who found potentially
serious pathology in 4.4% of all patients undergoing extracra-
nial CTAs for various indications.
CONCLUSION
The findings of this study suggest that CTAhas an impor-
tant benefit over conventional angiography in the ability todetect extravascular pathology. Although relatively few lesions
proved to be serious, the treatment delays associated with
further evaluation of benign lesions were modest. Manage-
ment does not end with the diagnosis of extravascular pathol-
ogy, however. Vascular surgeons must ensure proper fol-
low-up evaluation in all patients with suspicious lesions.
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